Federal Circuit Revives CRISPR-Cas9 Patent Priority Dispute | Wilson Sonsini

Outside the U.S., there is new litigation and ongoing legal proceedings with varying jurisdictional outcomes. Companies developing CRISPR-Cas9 based …